Business UpdateMay 26, 2026, 09:36 AM
Cosmos Health Projects 207% Revenue Growth to $200.6M by 2029
AI Summary
Cosmos Health Inc. announced its financial guidance for 2026-2029, projecting substantial growth across all key metrics. The company anticipates revenue to increase by 207% to $200.6 million by 2029, with gross profit growing 801% to $71.2 million and gross margins expanding to 35.5%. Cosmos Health expects to achieve net profitability in 2027, reaching $31.0 million by 2029, supported by a strategic shift towards high-margin proprietary products, operational leverage, and global expansion.
Key Highlights
- Revenue projected to increase 207% from $65.3M in 2025 to $200.6M by 2029 (32% CAGR).
- Gross profit expected to grow 801% from $7.9M in 2025 to $71.2M by 2029 (73% CAGR).
- Gross margin anticipated to expand from 12.1% in 2025 to 35.5% by 2029.
- Net income projected to improve by $50.1M, turning profitable in 2027, reaching $31.0M by 2029.
- Operating cash flow expected to turn positive in 2027 at $11.9M, growing to $24.0M by 2029.
- Cash and cash equivalents projected to increase 18-fold to $62.9M by 2029.
- Stockholders' equity projected to grow 402% to $92.3M by 2029.
- Non-diluted EPS projected to improve from ($0.42) in 2025 to $0.73 by 2029.
Price Impact
More from COSM